Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T Regulatory Cells in Pediatric Kidney Transplant
NCT01446484Phase 2Unknown
- Sponsor
- Pirogov Russian National Research Medical University
- Start
- Oct 2011
- Primary completion
- Nov 2014
- Modality
- Regulatory T Cells (Tregs), Native Immune Cells
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of PTG-007 in kidney transplant rejection (2 arms), sponsored by Pirogov Russian National Research Medical University. Primary endpoint: Patient and graft survival at 1 year. Status: unknown.
02
Drugs
PTG-007
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01446484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01446484.